Gabriel Brooks
Direttore Tecnico/Scientifico/R&S presso SOLID BIOSCIENCES INC.
Provenienza dei contatti di primo grado di Gabriel Brooks
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
| Public Company | Biotechnology | 19 | |
| Public Company | Biotechnology | 8 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Gabriel Brooks tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| GILEAD SCIENCES, INC. | Biotechnology | Chief Executive Officer | |
| PFIZER, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
| VERTEX PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | General Counsel Director of Finance/CFO Sales & Marketing | |
| RENTPATH INC | Internet Software/Services | Director/Board Member | |
| BIOGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Comptroller/Controller/Auditor | |
| QUEST DIAGNOSTICS INCORPORATED | Services to the Health Industry | Corporate Officer/Principal | |
| SAREPTA THERAPEUTICS, INC. | Pharmaceuticals: Major | General Counsel Corporate Officer/Principal Treasurer | |
The Robert Wood Johnson Foundation
 The Robert Wood Johnson Foundation Investment Trusts/Mutual FundsMiscellaneous The Robert Wood Johnson Foundation (RWJF) is an independent philanthropic organization headquartered in Princeton, New Jersey. The firm was founded in 1972 and is dedicated solely to health. RWJF funds a wide array of programs which are working to help build a national Culture of Health. | Investment Trusts/Mutual Funds | Corporate Officer/Principal | |
| ACORDA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| PTC THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
ViaCyte, Inc.
 ViaCyte, Inc. Pharmaceuticals: MajorHealth Technology ViaCyte, Inc. develops a stem cell-derived islet replacement therapy for the treatment of diabetes. Its development portfolio includes VC-01 product candidate, a cell replacement therapy for the treatment of type 1 diabetes. The company was founded in 1999 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| REATA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| DICERNA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| RA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Medocity, Inc.
 Medocity, Inc. Medical/Nursing ServicesHealth Services Medocity, Inc. develops a care platform that bridges the gap between the clinic and the patient?s home. It offers a patient-centric mobile solution that combines key aspects of disease-specific care into a platform that can be used on application and Web-based devices. The firm platform also tracks key symptoms and side effects in real time; displays reports and graphic summaries to understand the patient?s health status on a daily basis. The company is headquartered in Parsippany, NJ. | Medical/Nursing Services | Director/Board Member | |
Lung Therapeutics, Inc.
 Lung Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Lung Therapeutics, Inc. is a clinical stage pharmaceutical company, which engages in the development and commercialization of drugs for lung injury and disease. Its product pipelines include LTI-03 for the treatment of Idiopathic Pulmonary Fibrosis and LTI-01 for Loculated Pleural Effusion. The company was founded by Steven Idell and Andrew Mazar in 2012 and is headquartered in Austin, TX. | Pharmaceuticals: Major | Director/Board Member | |
University of Southern California
 University of Southern California Other Consumer ServicesConsumer Services University of Southern California is a private research university that mainly offers undergraduate, graduate & other higher education. The university was founded in 1880 and is headquartered in Los Angeles, CA. | College/University | Undergraduate Degree Graduate Degree | |
| Rutgers State University of New Jersey | College/University | Undergraduate Degree Doctorate Degree Undergraduate Degree | |
| Texas A&M University | College/University | Graduate Degree | |
| Yale University | College/University | Undergraduate Degree Corporate Officer/Principal Doctorate Degree | |
| Princeton University | College/University | Undergraduate Degree Undergraduate Degree Graduate Degree | |
| DAIICHI SANKYO CO., LTD. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Whitman College | College/University | Undergraduate Degree | |
Society of Kauffman Fellows
 Society of Kauffman Fellows Miscellaneous Commercial ServicesCommercial Services The Society of Kauffman Fellows is a venture capital fellowship program that aims to foster innovative leaders. The non-profit company is based in Palo Alto, CA. The program lasts for two years and includes industry events, summits, and a venture capital fund. The CEOs of the company are Jeff Harbach, Costello Trish. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| NOVOCURE LIMITED | Medical Specialties | Director/Board Member | |
Civitas Therapeutics, Inc.
 Civitas Therapeutics, Inc. BiotechnologyHealth Technology Civitas Therapeutics, Inc. develops transformative pulmonary delivery therapies. The company was founded by Glenn Batchelder, Richard P. Batycky, Martin I. Freed, Jennifer Fujii, Jeffrey Elton and James L. Wright on June 17, 2009 and is headquartered in Ardsley, NY. | Biotechnology | Founder Director/Board Member | |
G-CON Manufacturing, Inc.
 G-CON Manufacturing, Inc. Building ProductsProducer Manufacturing G-Con Manufacturing, Inc. provides design and construction services for pharmaceutical facilities. It maintains an integrated product team of engineers with bioprocess development, mechanical-electrical, and heating, ventilation, and air conditioning experience. The company was founded by Barry Holtz in 2009 and is headquartered in College Station, TX. | Building Products | Director/Board Member | |
| The University of North Carolina at Charlotte | College/University | Undergraduate Degree | |
Reflexion Medical, Inc.
 Reflexion Medical, Inc. Medical SpecialtiesHealth Technology Reflexion Medical, Inc. develops medical devices. Its products include marketwired resonate and influencers, news distribution, IR and PR hosted newsroom and media database. The company was founded by Akshay Nanduri and Samuel Mazin in 2009 and is headquartered in Hayward, CA. | Medical Specialties | Director/Board Member | |
| Columbia Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
Bain Capital Life Sciences LP
 Bain Capital Life Sciences LP Investment ManagersFinance Bain Capital Life Sciences LP (Bain Capital Life Sciences) is a private equity subsidiary of Bain Capital Private Equity LP, ultimately held by Bain Capital Holdings LP, founded in 2016. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Consultant / Advisor Private Equity Investor | |
ReCode Therapeutics, Inc.
 ReCode Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ReCode Therapeutics, Inc. operates as a biopharmaceutical company. It develops precision medicines for pulmonary diseases. The company is headquartered in Irvin, TX. | Pharmaceuticals: Major | Director/Board Member | |
| FOGHORN THERAPEUTICS INC. | Biotechnology | Director/Board Member Director/Board Member | |
Neurogene, Inc.
 Neurogene, Inc. BiotechnologyHealth Technology Neurogene, Inc. focuses on developing disease modifying therapeutics for severe neurologic diseases. Its pipeline includes multiple gene therapy products for ultra-rare diseases, as well as a novel technology that has the potential for use in monogenic autism spectrum disorders and indications not well suited for gene therapy. The company was founded by Rachel McMinn in January 2018 and is headquartered in New York, NY. | Biotechnology | Director/Board Member | |
| BRIDGEBIO PHARMA, INC. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
| TAYSHA GENE THERAPIES, INC. | Biotechnology | President Founder | |
Aavantibio, Inc.
 Aavantibio, Inc. BiotechnologyHealth Technology Aavantibio, Inc. engages in developing gene therapies. The company was founded by Barry Byrne and Manuela Corti and is headquartered in Gainesville, FL. | Biotechnology | Chief Operating Officer Director/Board Member Director/Board Member Chief Executive Officer General Counsel Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
SalioGen Therapeutics, Inc.
 SalioGen Therapeutics, Inc. BiotechnologyHealth Technology SalioGen Therapeutics, Inc. is a genetic medicine company based in Cambridge, MA. The company is advancing the Exact DNA Integration Technology (EDIT) platform, which is a mammal-derived genome engineering technology for use in potentially curative non-viral gene therapy. SalioGen Therapeutics has launched Gene Coding, a genetic medicine technology, to develop durable, broadly applicable genetic medicines using its EDIT platform. The company's mission is to transform the treatment paradigm for patients with inherited disorders. Jason F. Cole has been the CEO of the company since 2023. | Biotechnology | Director/Board Member | |
Jaguar Gene Therapy LLC
 Jaguar Gene Therapy LLC Medical/Nursing ServicesHealth Services Jaguar Gene Therapy LLC is a clinical stage biotechnology company based in Lake Forest, IL. Jaguar Gene Therapy LLC is dedicated to accelerating breakthroughs in gene therapy for patients suffering from severe genetic diseases. The company has a proven team of experts who have experience in bringing novel gene therapy treatments to patients and their families. Jaguar is rapidly advancing an initial pipeline of three programs, including targeting severe neurodevelopmental disorders, type 1 galactosemia, and type 1 diabetes. The company partner with Advanced Medicine Partners for manufacturing their therapeutics. Key investors include Deerfield Management Company, Arch Venture Partners, and Eli Lilly and Company. The company was founded by Daniel Gallo, and Joseph Nolan has been the CEO since 2020. | Medical/Nursing Services | Chief Tech/Sci/R&D Officer | |
Bright Peak Therapeutics, Inc.
 Bright Peak Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Bright Peak Therapeutics AG, Bright Peak Therapeutics, Inc. develops immunotherapies for the treatment of cancer and autoimmune diseases. The company is based in San Diego, CA. The company was founded by Vijaya R. Pattabiraman, Jeffrey Bode. The CEO is Fredrik Wiklund. | Pharmaceuticals: Major | Chairman | |
| Sandhill Therapeutics, Inc. | Director/Board Member | ||
| Rutgers Robert Wood Johnson Medical School | College/University | Doctorate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 48 |
| Francia | 2 |
| Giappone | 2 |
| Regno Unito | 2 |
Settori
| Health Technology | 30 |
| Consumer Services | 10 |
| Health Services | 4 |
| Finance | 4 |
| Technology Services | 2 |
Posizioni
| Director/Board Member | 146 |
| Corporate Officer/Principal | 56 |
| Independent Dir/Board Member | 52 |
| Undergraduate Degree | 25 |
| Chief Executive Officer | 15 |
Contatti più connessi
| Insiders | |
|---|---|
| Adam Koppel | 26 |
| Ian Smith | 24 |
| Susannah Gray | 20 |
| Bill Burkoth | 19 |
| Adam Stone | 18 |
| Jacob Chacko | 18 |
| Lynne Sullivan | 16 |
| Raj Shah | 16 |
| Martin Freed | 15 |
| Sukumar Nagendran | 15 |
| Georgia Keresty | 15 |
| R. Session | 13 |
| August Moretti | 10 |
| John Milligan | 9 |
| Margaret McLoughlin | 9 |
- Borsa valori
- Insiders
- Gabriel Brooks
- Connessioni Società
